Chinese radiopharmaceutical startup C Ray Therapeutics announced on Saturday that it has raised over $100 million in a Series A+ funding round to
Eudora Wang is a Senior Reporter for DealStreetAsia, with her work also appearing in Nikkei Asia. She specializes in covering various topics related to finance, investment, and business in China and Asia. Eudora's articles provide insights into the latest market trends, fundraising activities, and developments in the region's healthcare, technology, and consumer sectors.